CURE | SPXL | CURE / SPXL | |
Gain YTD | 17.521 | 4.778 | 367% |
Net Assets | 174M | 5.28B | 3% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 18.00 | 65.00 | 28% |
Yield | 1.53 | 0.86 | 178% |
Fund Existence | 14 years | 16 years | - |
CURE | SPXL | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | N/A |
Stochastic ODDS (%) | 2 days ago90% | 2 days ago90% |
Momentum ODDS (%) | 2 days ago89% | 2 days ago90% |
MACD ODDS (%) | 2 days ago84% | 2 days ago90% |
TrendWeek ODDS (%) | 2 days ago89% | 2 days ago88% |
TrendMonth ODDS (%) | 2 days ago90% | 2 days ago89% |
Advances ODDS (%) | 3 days ago90% | 4 days ago90% |
Declines ODDS (%) | 5 days ago90% | 2 days ago89% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago85% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago89% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HDCEX | 9.62 | -0.11 | -1.13% |
Rational Equity Armor Fund C | |||
LAVYX | 15.79 | -0.27 | -1.68% |
Lord Abbett Fundamental Equity I | |||
PLFPX | 29.56 | -0.51 | -1.70% |
Principal Large Cap S&P 500 Index R5 | |||
DEYCX | 12.62 | -0.29 | -2.25% |
BNY Mellon Large Cap Equity C | |||
GPTUX | 13.59 | -0.35 | -2.54% |
GuidePath® Tactical Allocation Svc |
A.I.dvisor indicates that over the last year, SPXL has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPXL jumps, then MSFT could also see price increases.
Ticker / NAME | Correlation To SPXL | 1D Price Change % | ||
---|---|---|---|---|
SPXL | 100% | -5.13% | ||
MSFT - SPXL | 63% Loosely correlated | -1.90% | ||
AAPL - SPXL | 62% Loosely correlated | -0.11% | ||
AMZN - SPXL | 60% Loosely correlated | -2.83% | ||
META - SPXL | 59% Loosely correlated | -1.62% | ||
NVDA - SPXL | 56% Loosely correlated | -4.05% | ||
More |